Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Alembic Pharmaceuticals Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue2.002.002.002.002.00
      
      
INCOME     
Revenue From Operations [Net]6539.716112.115499.775231.795276.22
Other Operating Revenues132.37116.51152.8574.00116.91
Total Operating Revenues6672.086228.625652.625305.795393.13
      
Other Income42.5528.312.7450.4610.02
Total Revenue6714.636256.935655.365356.255403.15
      
EXPENSES     
Cost Of Materials Consumed1672.171403.011250.081129.111185.35
Purchase Of Stock-In Trade410.96454.91380.09360.50265.92
Operating And Direct Expenses0.000.0050.900.0022.39
Changes In Inventories Of FG,WIP And Stock-In Trade-289.77-142.8478.65-43.19-193.93
Employee Benefit Expenses1562.341446.291169.131133.001051.17
Finance Costs78.7756.1950.1717.7316.02
Depreciation And Amortisation Expenses278.58272.67275.43286.78183.47
Other Expenses2308.142133.902015.391852.211504.68
Total Expenses6021.195624.135269.844736.144035.07
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax693.44632.80385.52620.111368.08
      
Exceptional Items12.870.000.000.000.00
Profit/Loss Before Tax706.31632.80385.52620.111368.08
      
Tax Expenses-Continued Operations     
Current Tax122.6965.814.20129.18255.47
Deferred Tax2.99-46.069.20-23.47-9.56
Tax For Earlier Years-0.51-3.75-0.79-1.257.41
Total Tax Expenses125.1716.0012.61104.46253.32
Profit/Loss After Tax And Before ExtraOrdinary Items581.14616.80372.91515.651114.76
      
Profit/Loss From Continuing Operations581.14616.80372.91515.651114.76
      
Profit/Loss For The Period581.14616.80372.91515.651114.76
      
Minority Interest1.410.000.000.0031.61
Share Of Profit/Loss Of Associates0.87-0.98-30.925.2931.74
Consolidated Profit/Loss After MI And Associates583.42615.82341.99520.941178.11
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)29.6831.3317.4026.5060.81
Diluted EPS (Rs.)29.6831.3317.4026.5060.81
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend216.22157.25196.56275.190.00
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue2.00
  
INCOME 
Revenue From Operations [Net]6539.71
Other Operating Revenues132.37
Total Operating Revenues6672.08
Other Income42.55
Total Revenue6714.63
EXPENSES 
Cost Of Materials Consumed1672.17
Purchase Of Stock-In Trade410.96
Operating And Direct Expenses0.00
Changes In Inventories Of FG,WIP And Stock-In Trade-289.77
Employee Benefit Expenses1562.34
Finance Costs78.77
Depreciation And Amortisation Expenses278.58
Other Expenses2308.14
Total Expenses6021.19
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax693.44
Exceptional Items12.87
Profit/Loss Before Tax706.31
Tax Expenses-Continued Operations 
Current Tax122.69
Deferred Tax2.99
Tax For Earlier Years-0.51
Total Tax Expenses125.17
Profit/Loss After Tax And Before ExtraOrdinary Items581.14
Profit/Loss From Continuing Operations581.14
Profit/Loss For The Period581.14
Minority Interest1.41
Share Of Profit/Loss Of Associates0.87
Consolidated Profit/Loss After MI And Associates583.42
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)29.68
Diluted EPS (Rs.)29.68
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend216.22